Kate Butler
Kate Butler is Chief Financial Officer of Syncona Investment Management Ltd.
Kate is a Director on the Board of Slingshot Therapeutics. Kate joined Syncona Investment Management Ltd. in 2022 as Group Finance Director, and subsequently was promoted to CFO, effective April 2024. She is a senior finance leader with over 20 years’ experience in finance and a wealth of experience across multiple roles in the life sciences sector. Kate joined Syncona from Awakn, a Canadian listed biotech start up where she was CFO. Prior to that she held senior roles in the finance teams at Vectura plc, Gilead Sciences Inc., and Kite Europe. Kate also has FTSE 100 experience working with Anglo American plc and spent nine years at Ernst & Young LLP, where she qualified as a chartered accountant
Syncona portfolio companies
- Slingshot Therapeutics (Director)
